Completely agree with the stance. Protein modelling is one part of the enormous jigsaw that is drug development. Structural biology is already a computational savvy discipline that is accustomed to using available tooling/predictions to enable better decisions with spare/minimal data. Sometimes the predictions are good, sometimes bad, but they are always being reviewed by a human expert. Maybe alpha fold is significantly better than the competition -then it is likely to make solving structures faster.
Hypothetical: the protein structures of all human proteins were solved tomorrow -is human disease cured? No, far from it, there is so much development work that goes beyond knowing the accessible pockets on a protein.